SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-031417
Filing Date
2011-03-31
Accepted
2011-03-31 15:07:05
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K b84090e10vk.htm 10-K 607303
2 EX-10.54 b84090exv10w54.htm EX-10.54 7671
3 EX-10.60 b84090exv10w60.htm EX-10.60 7628
4 EX-10.61 b84090exv10w61.htm EX-10.61 7939
5 EX-21 b84090exv21.htm EX-21 2550
6 EX-23.1 b84090exv23w1.htm EX-23.1 1626
7 EX-31.1 b84090exv31w1.htm EX-31.1 8195
8 EX-31.2 b84090exv31w2.htm EX-31.2 8592
9 EX-32.1 b84090exv32w1.htm EX-32.1 2969
10 EX-32.2 b84090exv32w2.htm EX-32.2 3416
11 GRAPHIC b84090b8409001.gif GRAPHIC 5766
  Complete submission text file 0000950123-11-031417.txt   667285
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-06533 | Film No.: 11725657
SIC: 2834 Pharmaceutical Preparations